Alnylam Pharmaceuticals
ALNY
#458
Rank
ยฃ38.35 B
Marketcap
ยฃ290.35
Share price
-5.99%
Change (1 day)
45.85%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company